These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3309545)
1. Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones. Svenson KL; Lundqvist G; Wide L; Hällgren R Metabolism; 1987 Oct; 36(10):940-3. PubMed ID: 3309545 [TBL] [Abstract][Full Text] [Related]
2. Impaired glucose handling in active rheumatoid arthritis: effects of corticosteroids and antirheumatic treatment. Svenson KL; Lundqvist G; Wide L; Hällgren R Metabolism; 1987 Oct; 36(10):944-8. PubMed ID: 3309546 [TBL] [Abstract][Full Text] [Related]
3. [Insulin, glucagon and growth hormone responses during glucose, arginine and insulin tolerance tests in children with hyperthyroidism]. Kato T; Matsuura N; Fujita H; Fujieda K; Nohara Y; Mikami Y; Abe K; Fukushima N Nihon Naibunpi Gakkai Zasshi; 1985 Jun; 61(6):665-76. PubMed ID: 3902521 [TBL] [Abstract][Full Text] [Related]
4. Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Svenson KL; Pollare T; Lithell H; Hällgren R Metabolism; 1988 Feb; 37(2):125-30. PubMed ID: 2893241 [TBL] [Abstract][Full Text] [Related]
5. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver. Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447 [TBL] [Abstract][Full Text] [Related]
6. Glucose intolerance in uraemia. II. Plasma growth hormone and glucagon values. Tchobroutky G; Rosselin G; Assan R; Derot M Diabetologia; 1969 Feb; 5(1):25-8. PubMed ID: 5373804 [No Abstract] [Full Text] [Related]
7. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA; Cryer PE; Gerich JE J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory action of somatostatin on pancreatic alpha and beta cell function. Leblanc H; Anderson JR; Sigel MB; Yen SS J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707 [TBL] [Abstract][Full Text] [Related]
9. [Relationship between fasting glycemia, serum peptide C, insulin, growth hormone and plasma glucagon in acromegaly]. Piniewska-Hułas D; Lewandowski Z; Kasperska-Dworak A; Bonicki W Pol Arch Med Wewn; 1996 Jun; 95(6):524-33. PubMed ID: 9005421 [TBL] [Abstract][Full Text] [Related]
10. Transient diabetes mellitus in a neonate. Evaluation of insulin, glucagon, and growth hormone secretion and management with a continuous low-dose insulin infusion. Sodoyez-Goffaux F; Sodoyez JC J Pediatr; 1977 Sep; 91(3):395-9. PubMed ID: 894407 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic alpha-cell function in idiopathic reactive hypoglycemia. Ahmadpour S; Kabadi UM Metabolism; 1997 Jun; 46(6):639-43. PubMed ID: 9186298 [TBL] [Abstract][Full Text] [Related]
12. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062 [TBL] [Abstract][Full Text] [Related]
13. Glucose, growth hormone, cortisol, and insulin responses to glucagon injection in normal infants, aged 0.5-12 months. Chanoine JP; Rebuffat E; Kahn A; Bergmann P; Van Vliet G J Clin Endocrinol Metab; 1995 Oct; 80(10):3032-5. PubMed ID: 7559892 [TBL] [Abstract][Full Text] [Related]
14. Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Paolisso G; Giugliano D; Pizza G; Gambardella A; Tesauro P; Varricchio M; D'Onofrio F Diabetes Care; 1992 Jan; 15(1):1-7. PubMed ID: 1737525 [TBL] [Abstract][Full Text] [Related]
15. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
16. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. Larsson H; Berglund G; Ahrén B J Clin Endocrinol Metab; 1995 Jun; 80(6):1778-82. PubMed ID: 7775622 [TBL] [Abstract][Full Text] [Related]
17. Suppression and stimulation mechanisms controlling glucagon secretion in a case of islet-cell tumor producing glucagon, insulin, and gastrin. Tiengo A; Fedele D; Marchiori E; Nosadini R; Muggeo M Diabetes; 1976 May; 25(5):408-12. PubMed ID: 5326 [TBL] [Abstract][Full Text] [Related]
18. [Secretion of insulin and growth hormone during glucagon loading in obesity]. Masuda K; Chikamori K; Hirano M; Fujinaka S; Tetsuka U Horumon To Rinsho; 1974 Jul; 22(7):847-52. PubMed ID: 4473056 [No Abstract] [Full Text] [Related]
19. Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. Paolisso G; Valentini G; Giugliano D; Marrazzo G; Tirri R; Gallo M; Tirri G; Varricchio M; D'Onofrio F Metabolism; 1991 Sep; 40(9):902-7. PubMed ID: 1895954 [TBL] [Abstract][Full Text] [Related]